Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Pegvaliase is recommended for treating adults with phenylketonuria.

GD-23 reduces anxiety by relying on neurosteroid production.

SHPro® improved urinary symptoms and erectile function in men and is safe.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.

Low-dose finasteride can cause painful breast enlargement in men, which resolves after stopping the medication.

Finasteride effectively reduces prostate size in dogs with benign prostatic hyperplasia at a low, safe dose.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Using tamsulosin with finasteride is the most effective and reduces surgery risk for BPH.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Some common medications can lower PSA levels in 45-year-old German men.

Using a strong allergy medicine too often on the scalp can cause swelling and inflammation.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.